SIGNATURE: A workbench for gene expression signature analysis

Acta Veterinaria Scandinavica

Volumn 53, Issue 1, 2011, Pages

  Chang, Jeffrey T ^a   Gatza, Michael L ^b   Lucas, Joseph E ^b   Barry, William T ^b   Vaughn, Peyton ^b   Nevins, Joseph R ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; BAYES THEOREM; COMPUTER INTERFACE; COMPUTER PROGRAM; GENE EXPRESSION PROFILING; GENETIC DATABASE; INTERNET; METHODOLOGY;

ALGORITHMS; BAYES THEOREM; DATABASES, GENETIC; GENE EXPRESSION PROFILING; INTERNET; SOFTWARE; USER-COMPUTER INTERFACE;

BAYESIAN METHODS; BIOLOGICAL DATA; BIOLOGICAL PHENOTYPES; GENE EXPRESSION ANALYSIS; GENE EXPRESSION DATA; GENE EXPRESSION SIGNATURES; INTELLIGENT SOFTWARE TOOLS; WEB-BASED RESOURCES;

APPLICATION PROGRAMS; BAYESIAN NETWORKS; COMPUTATIONAL METHODS; DATA HANDLING;

GENE EXPRESSION;

EID: 84855487753     PISSN: 0044605X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2105-12-443     Document Type: Article

References (33)

1. West M, Ginsburg GS, Huang AT, Nevins JR. Embracing the complexity of genomic data for personalized medicine. Genome Res 2006, 16(5):559-566. 10.1101/gr.3851306, 16651662.
2. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102(43):15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
3. Culhane AC, Schwarzl T, Sultana R, Picard KC, Picard SC, Lu TH, Franklin KR, French SJ, Papenhausen G, Correll M, Quackenbush J. GeneSigDB--a curated database of gene expression signatures. Nucleic Acids Res 2010, 38(Database issue):D716-725. 2808880, 19934259.
4. Chang JT, Nevins JR. GATHER: a systems approach to interpreting genomic signatures. Bioinformatics 2006, 22(23):2926-2933. 10.1093/bioinformatics/btl483, 17000751.
5. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313(5795):1929-1935. 10.1126/science.1132939, 17008526.
6. Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C, Frohling S, Chan EM, Sos ML, Michel K, Mermel C, Silver SJ, Weir BA, Reiling JH, Sheng Q, Gupta PB, Wadlow RC, Le H, Hoersch S, Wittner BS, Ramaswamy S, Livingston DM, Sabatini DM, Meyerson M, Thomas RK, Lander ES, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009, 462(7269):108-112. 10.1038/nature08460, 2783335, 19847166.
7. Furge KA, Chen J, Koeman J, Swiatek P, Dykema K, Lucin K, Kahnoski R, Yang XJ, Teh BT. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res 2007, 67(7):3171-3176. 10.1158/0008-5472.CAN-06-4571, 17409424.
8. Huang F, Reeves K, Han X, Fairchild C, Platero S, Wong TW, Lee F, Shaw P, Clark E. Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection. Cancer Res 2007, 67(5):2226-2238. 10.1158/0008-5472.CAN-06-3633, 17332353.
9. Langenau DM, Keefe MD, Storer NY, Guyon JR, Kutok JL, Le X, Goessling W, Neuberg DS, Kunkel LM, Zon LI. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev 2007, 21(11):1382-1395. 10.1101/gad.1545007, 1877750, 17510286.
10. Loboda A, Nebozhyn M, Klinghoffer R, Frazier J, Chastain M, Arthur W, Roberts B, Zhang T, Chenard M, Haines B, Andersen J, Nagashima K, Paweletz C, Lynch B, Feldman I, Dai H, Huang P, Watters J. A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors. BMC Med Genomics 2010, 3:26. 10.1186/1755-8794-3-26, 2911390, 20591134.
11. Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, Tao J, Ward L, Koo JH, Gopalakrishnan V, Zhu Y, Cheng LL, Lee J, Rha SY, Chung HC, Ganesan K, So J, Soo KC, Lim D, Chan WH, Wong WK, Bowtell D, Yeoh KG, Grabsch H, Boussioutas A, Tan P. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet 2009, 5(10):e1000676. 10.1371/journal.pgen.1000676, 2748685, 19798449.
12. Rhodes DR, Kalyana-Sundaram S, Tomlins SA, Mahavisno V, Kasper N, Varambally R, Barrette TR, Ghosh D, Varambally S, Chinnaiyan AM. Molecular concepts analysis links tumors, pathways, mechanisms, and drugs. Neoplasia 2007, 9(5):443-454. 10.1593/neo.07292, 1877973, 17534450.
13. Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N, Settleman J. A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell 2009, 15(6):489-500. 10.1016/j.ccr.2009.03.022, 2743093, 19477428.
14. Wong DJ, Liu H, Ridky TW, Cassarino D, Segal E, Chang HY. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008, 2(4):333-344. 10.1016/j.stem.2008.02.009, 2628721, 18397753.
15. Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, Foekens JA, Massague J. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 2009, 16(1):67-78. 10.1016/j.ccr.2009.05.017, 2749247, 19573813.
16. Liu Z, Wang M, Alvarez JV, Bonney ME, Chen CC, D'Cruz C, Pan TC, Tadesse MG, Chodosh LA. Singular value decomposition-based regression identifies activation of endogenous signaling pathways in vivo. Genome Biol 2008, 9(12):R180. 10.1186/gb-2008-9-12-r180, 2646284, 19094238.
17. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, Su Z, Chu TM, Goodsaid FM, Pusztai L, Shaughnessy JD, Oberthuer A, Thomas RS, Paules RS, Fielden M, Barlogie B, Chen W, Du P, Fischer M, Furlanello C, Gallas BD, Ge X, Megherbi DB, Symmans WF, Wang MD, Zhang J, Bitter H, Brors B, Bushel PR, Bylesjo M, et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 2010, 28(8):827-838. 10.1038/nbt.1665, 20676074.
18. Kumar S, Dudley J. Bioinformatics software for biologists in the genomics era. Bioinformatics 2007, 23(14):1713-1717. 10.1093/bioinformatics/btm239, 17485425.
19. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series 1999, 41:95-98.
20. Gotz S, Garcia-Gomez JM, Terol J, Williams TD, Nagaraj SH, Nueda MJ, Robles M, Talon M, Dopazo J, Conesa A. High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res 2008, 36(10):3420-3435. 10.1093/nar/gkn176, 2425479, 18445632.
21. Kumar S, Nei M, Dudley J, Tamura K. MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 2008, 9(4):299-306. 10.1093/bib/bbn017, 2562624, 18417537.
22. Richter M, Lombardot T, Kostadinov I, Kottmann R, Duhaime MB, Peplies J, Glockner FO. JCoast - a biologist-centric software tool for data mining and comparison of prokaryotic (meta)genomes. BMC Bioinformatics 2008, 9:177. 10.1186/1471-2105-9-177, 2311307, 18380896.
23. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA, Marks JR, Nevins JR. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 2001, 98(20):11462-11467. 10.1073/pnas.201162998, 58752, 11562467.
24. Spang R, Zuzan H, West M, Nevins J, Blanchette C, Marks JR. Prediction and uncertainty in the analysis of gene expression profiles. In Silico Biol 2002, 2(3):369-381.
25. Gatza ML, Lucas JE, Barry WT, Kim JW, Wang Q, Crawford MD, Datto MB, Kelley M, Mathey-Prevot B, Potti A, Nevins JR. A pathway-based classification of human breast cancer. Proc Natl Acad Sci USA 2010, 107(15):6994-6999. 10.1073/pnas.0912708107, 2872436, 20335537.
26. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31(4):e15. 10.1093/nar/gng015, 150247, 12582260.
27. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP. GenePattern 2.0. Nat Genet 2006, 38(5):500-501. 10.1038/ng0506-500, 16642009.
28. Leek JT, Scharpf RB, Bravo HC, Simcha D, Langmead B, Johnson WE, Geman D, Baggerly K, Irizarry RA. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet 2010, 11(10):733-739. 10.1038/nrg2825, 20838408.
29. Barnes M, Freudenberg J, Thompson S, Aronow B, Pavlidis P. Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms. Nucleic Acids Res 2005, 33(18):5914-5923. 10.1093/nar/gki890, 1258170, 16237126.
30. Maouche S, Poirier O, Godefroy T, Olaso R, Gut I, Collet JP, Montalescot G, Cambien F. Performance comparison of two microarray platforms to assess differential gene expression in human monocyte and macrophage cells. BMC Genomics 2008, 9:302. 10.1186/1471-2164-9-302, 2464609, 18578872.
31. Lucas J, Carvalho C, Wang Q, Bild A, Nevins JR, West M. Sparse statistical modelling in gene expression genomics. Bayesian Inference for Gene Expression and Proteomics 2006, 155-176. Cambridge University Press, Do KA, Muller P, 1.
32. Chang JT, Carvalho C, Mori S, Bild AH, Gatza ML, Wang Q, Lucas JE, Potti A, Febbo PG, West M, Nevins JR. A genomic strategy to elucidate modules of oncogenic pathway signaling networks. Mol Cell 2009, 34(1):104-114. 10.1016/j.molcel.2009.02.030, 2694616, 19362539.
33. Lucas JE, Carvalho CM, Chen JL, Chi JT, West M. Cross-study projections of genomic biomarkers: an evaluation in cancer genomics. PLoS One 2009, 4(2):e4523. 10.1371/journal.pone.0004523, 2638006, 19225561.